Patents Assigned to Valentis, Incorporated
  • Cationic lipid DNA complexes for gene targeting
    Patent number: 5932241
    Abstract: This invention herein describes pharmaceutical compositions and methods for targeted delivery of functional genes into cells and tissues in vivo. The invention discloses DNA:lipid complexes, methods of making such complexes and methods of using such complexes for facilitating the targeted delivery and entry of recombinant expression constructs into cells and tissues in vivo, and particularly delivery of such recombinant expression constructs to lung cells and tissues.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: August 3, 1999
    Assignee: Valentis, Incorporated
    Inventor: Cori M. Gorman